FDA Approved: DSUVIA — Supplemental Application (AcelRx Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DSUVIA (sufentanil) by AcelRx Pharmaceuticals, Inc., pertaining to this analgesic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• DSUVIA (SUFENTANIL)

Snippet

SUPPL AP for DSUVIA (SUFENTANIL)